...
机译:测试个性化药物:晚期癌症护理中下一代基因组测序的患者和医生期望
Institute of Health Policy Management and Evaluation University of Toronto 155 College St;
Institute of Health Policy Management and Evaluation University of Toronto 155 College St;
Institute of Health Policy Management and Evaluation University of Toronto 155 College St;
Princess Margaret Cancer Centre-University Health Network Toronto ON Canada;
London Health Sciences Centre London ON Canada;
Juravinski Cancer Centre Hamilton ON Canada;
Juravinski Cancer Centre Hamilton ON Canada;
Princess Margaret Cancer Centre-University Health Network Toronto ON Canada;
Princess Margaret Cancer Centre-University Health Network Toronto ON Canada;
London Health Sciences Centre London ON Canada;
London Health Sciences Centre London ON Canada;
Ontario Institute for Cancer Research Toronto ON Canada;
Princess Margaret Cancer Centre-University Health Network Toronto ON Canada;
cancer care; clinical sequencing; clinical trials; genetic testing; personalized medicine; qualitative research;
机译:测试个性化药物:患者和医师对晚期癌症治疗中下一代基因组测序的期望
机译:测试个性化药物:晚期癌症护理中下一代基因组测序的患者和医生期望
机译:开创性的同意对研究结果的回报,对乳腺癌患者面临基因组医学的障碍:肯尼亚BRCA1 / 2使用全外壳测序的测试经验
机译:医生是否准备好利用基因组学来实现个性化实践,并且他们希望在患者基因组信息系统中拥有什么?
机译:基因组学后方法用于个性化医学:外显子组测序,微生物组和COPD中的应用。
机译:测试个性化药物:患者和医生对晚期癌症治疗中下一代基因组测序的期望
机译:开创性的同意对研究结果的回报,对乳腺癌患者面临基因组医学的障碍:肯尼亚BRCA1 / 2使用全外壳测序的测试经验